GoodRx Holdings, Inc.
GDRX Healthcare Health Information Services
GoodRx Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $796.9 million, up 0.57% from fiscal 2024. In the quarter to June 2026, revenue fell 1.31%, EPS fell 25.0%, free cash flow grew 112.5% and total debt was flat, each against the same quarter a year earlier.
Follow GDRX
GoodRx Holdings, Inc. (GDRX) EV/Sales
As of 16 October 2026, GoodRx Holdings, Inc. (GDRX) trades at a EV/Sales of 1.7×. Over the past ten years it has ranged from 1.1× (February 2026) to 30.0× (September 2021); the current reading is higher than 13% of that period. That is below the Health Information Services industry median of 2.6× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.5× | (35.48%) |
| FY2024 | 2.3× | (24.05%) |
| FY2023 | 3.1× | 26.74% |
| FY2022 | 2.4× | (86.32%) |
| FY2021 | 17.6× | (10.06%) |
| FY2020 | 19.6× | (24.54%) |
| FY2019 | 25.9× | 0.00% |
| FY2018 | 25.9× | 0.00% |
| FY2017 | 25.9× | 0.00% |
| FY2016 | 25.9× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.5× | 27.46% |
| Mar 2026 | 1.2× | (22.02%) |
| Dec 2025 | 1.5× | (28.81%) |
| Sep 2025 | 2.1× | (15.31%) |
| 24 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| MDRX Veradigm Inc. compare | 0.6× |
| TDOC Teladoc Health, Inc. compare | 0.9× |
| OMCL Omnicell, Inc. compare | 1.3× |
| PHR Phreesia, Inc. compare | 1.5× |
| GDRX GoodRx Holdings, Inc. | 1.7× |
| OMDA Omada Health, Inc. compare | 2.8× |
| HSTM HealthStream, Inc. compare | 2.9× |
| CERT Certara, Inc. compare | 3.7× |
| SDGR Schrodinger, Inc. compare | 4.9× |
| Health Information Services industry median | 2.6× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)